SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$2.46 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-31
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$2.46M.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$1.92M.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$1.38M.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$1.05M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$2.46M 10-K · filed 2026-03-31 | |
| 2024-12-31 | -$1.92M 10-K · filed 2025-02-26 | |
| 2023-12-31 | -$1.38M 10-K · filed 2025-02-26 | |
| 2022-12-31 | -$1.05M 10-K/A · filed 2024-09-04 | -$635.97K 10-K · filed 2023-03-15 |
| 2021-12-31 | -$153.75K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |